FDA warning letters
A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.
175 letters match. Newest first.
-
DrugsBeijing Xinggu Lvsan Technology Co., Ltd. Formerly known as Beijing Lvsan Technology Co., Ltd.
FDA cites Beijing Xinggu Lvsan for manufacturing-rule failures and unapproved, misbranded hand sanitizers.
High risk -
DrugsAmerican Cleaning Solutions
FDA warned American Cleaning Solutions after a 2022 inspection found hand sanitizer made with inadequate cleaning, unvalidated processes, and substituted ethanol.
High risk -
DrugsSanitizer Supply LLC
FDA warns Sanitizer Supply LLC that its hand sanitizer wipes and sanitizers lacked required potency and microbial testing before release.
High risk -
DrugsEpisciences Inc.
FDA warns Episciences Inc. that its Boise, Idaho plant made OTC drugs without adequate batch testing, process validation and failure investigations.
High risk -
DrugsGordon Laboratories Inc.
FDA: Gordon Laboratories' artnaturals hand sanitizer held benzene and acetaldehyde impurities, and CGMP failures let them happen.
High risk -
DrugsMirfeel Korea Co., Ltd.
Mirfeel Korea's hand sanitizer contained benzene and had testing failures; FDA also says food-pouch packaging misbranded.
High risk -
DrugsFagron Group B.V.
FDA warns Fagron over cleaning and cross-contamination failures in active pharmaceutical ingredient repackaging.
High risk -
FoodDLG Naturals, Inc.
DLG Naturals sold shea butter, seed oils, and Kigelia extract as unapproved new drugs (not FDA-approved) with disease-treatment claims on its website.
Medium -
FoodMCACO, LTD
FDA cited MCACO for manufacturing-quality violations in its dietary supplements.
Medium -
FoodMYA International, Inc.
FDA warned MYA International that its supplement and herbal product labels made unapproved drug claims and its dietary supplements violated manufacturing quality and labeling rules.
High risk -
DrugsGeneritech Corporation
FDA warned Generitech Corporation of Fresno, California over CGMP failures in its topical drug manufacturing and unapproved hydroquinone skin bleaching creams.
High risk -
DrugsYusef Manufacturing Laboratories, LLC
FDA warned Yusef Manufacturing Laboratories over serious CGMP violations in its OTC drugs and hand sanitizers, including untested ethanol.
High risk -
DrugsPremier Trends LLC
FDA warned Premier Trends over manufacturing-quality failures and missing FDA registration/listing for its Magic Heal skin drug.
High risk -
DrugsChameleon Beverage Co. Inc. dba Chameleon Sanitizer Corporation
FDA warned Chameleon Sanitizer Corporation that its hand sanitizer was made under insanitary conditions and violated manufacturing and misbranding rules.
High risk -
FoodJule's Foods
FDA tied Jule's Foods' ready-to-eat vegan cashew brie to a multi-state Salmonella outbreak and cited insanitary conditions.
High risk -
DrugsFurley Bioextracts SDN BHD
FDA warns Furley Bioextracts over manufacturing failures and unapproved PainFix Relief Gel for the U.S. market.
High risk -
DrugsGulsah Uretim Kozmetik Sanayi Anonim Sirketi
Turkish OTC drug maker Gulsah failed to test its products and ingredients, and FDA blocked its U.S. imports.
High risk -
FoodSTB Quarters, LLC
Chicago importer STB Quarters had no foreign supplier verification program for its imported tahini/sesame paste and sesame seeds.
High risk -
FoodTuty Usa LLC
Tuty USA lacked FSVP records verifying foreign suppliers for imported wheat snacks, Japanese peanuts, and cookies, FDA says.
Medium -
DrugsIncredible Products, SA de CV
FDA found Incredible Products’ GELBACT hand sanitizer labeled 80% ethanol contained 67% methanol and little ethanol.
High risk -
DrugsBiotek India
Biotek India, an OTC drug maker, lacked active-ingredient testing and sold an unapproved 99% isopropyl rubbing alcohol.
High risk -
DrugsBioLyte Laboratories, LLC
FDA cited BioLyte Laboratories for manufacturing failures and unapproved silver, CBD, and magnesium drug products.
High risk -
DrugsDibar Nutricional S. de R.L. de C.V.
Dibar Nutricional's OTC drugs drew FDA CGMP violations and an import alert over missing testing.
High risk -
DrugsProfessional Compounding Centers of America dba PCCA
PCCA received adulterated drug ingredients from suppliers on FDA import alerts and failed adequate glycerin identity testing.
High risk -
DrugsYuyao YiJia Daily Chemical Co., Ltd.
Yuyao YiJia, a Chinese OTC drug and hand sanitizer maker, lacked finished-product, component and stability testing and an adequate quality unit.
High risk